SubHero Banner
Text

Aristada® (aripiprazole lauroxil) – New formulation approval

June 6, 2017 – Alkermes announced the FDA approval of two-month Aristada (aripiprazole lauroxil) extended-release injectable suspension, for the treatment of schizophrenia.

Download PDF